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Fibronectin and its major receptor, integrin α5β1 are required for embryogenesis. These mutants have
similar phenotypes, although, defects in integrin α5-deﬁcient mice are milder. In this paper, we
examined heart development in those mutants, in which the heart is formed, and discovered that both
ﬁbronectin and integrin α5 were required for cardiac morphogenesis, and in particular, for the formation
of the cardiac outﬂow tract. We found that Isl1+ precursors are speciﬁed and migrate into the heart in
ﬁbronectin- or integrin α5-mutant embryos, however, the hearts in these mutants are of aberrant shape,
and the cardiac outﬂow tracts are short and malformed. We show that these defects are likely due to the
requirement for cell adhesion to ﬁbronectin for proliferation of myocardial progenitors and for Fgf8
signaling in the pharyngeal region.
& 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Cardiovascular morphogenesis is a complex process that
requires extensive communication and interactions between
progenitor cells derived from all germ layers (Rentschler et al.,
2010). Cellular components of the three germ layers and the neural
crest participate in these interactions, and signaling by growth
factors from and to speciﬁc tissues in proximity with cardiac
progenitors is important (Astrof, 2013). However, how various
signaling pathways are orchestrated and integrated during cardiac
development is not well understood.
Gene knock out studies have shown that extracellular matrix
(ECM) proteins play essential roles in organ morphogenesis in vivo
(Aszodi et al., 2006; Wickstrom et al., 2011). For example, laminins
containing γ1 or β1 chains are essential for the generation of
endodermal cell polarity and formation of the Reichert's mem-
brane, and their absence leads to peri-implantation lethality
(Miner et al., 2004; Miner and Yurchenco, 2004); Fibronectin
(FN), ﬁbulin-1, and collagen V are required for vascularInc.
f).
Einstein College of Medicine,
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known to modulate growth factor signaling and inﬂuence cell fate
decisions through interactions with their cellular receptors such as
integrins (Hynes, 2009). For example, mesenchymal stem cells
adopt different cell fates depending on the stiffness of the ECM
substrate (Engler et al., 2006). Endothelial cells plated on ﬁbro-
nectin (FN) proliferate, while those plated on laminin 111, exit
from cell cycle and form endothelial tubes/vascular channels
(Giancotti and Tarone, 2003). However, despite exciting new
progress in understanding the roles of ECM proteins in vivo
(Lindsay and Dietz, 2011), molecular mechanisms underlying
functions of the majority of the ECM components in vivo are not
well-understood.
FN is a large ECM glycoprotein encoded by a single gene in mice
and humans. FN is unique to vertebrates (Hynes, 2012). It has been
hypothesized that FN evolved with vertebrate features such as
closed, endothelial-lined vasculature, the multi-potent neural crest
and bones and is important for the development and function of
these vertebrate innovations (Hynes, 2012). Indeed, global FN-null
mouse embryos die by mid-gestation with severe defects in
vascular and neural crest development, and conditional ablation
of FN protein from the blood plasma leads to incomplete blood
clotting and aberrant wound healing following brain ischemia
(George et al., 1997; Mittal et al., 2010; Ni et al., 2003; Sakai et al.,
2001).
In order to understand molecular roles of FN in vertebrate
morphogenesis, one ﬁrst needs to understand the features of
embryonic development dependent on FN's function. In ourse.
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genesis of the mouse node and establishment of the left–right
asymmetry at the early stages of mouse development (Pulina et al.,
2011). We found that FN is also important for the maintenance of
the embryonic left–right body plan by regulating expression of
Lefty1 at the midline and maintaining integrity of the notochord.
FN is also required for the proper development of the heart and
early embryonic and extraembryonic blood vessels (George et al.,
1997, 1993; Georges-Labouesse et al., 1996). In addition, prior
experiments indicated that FN is important for formation of a
single cardiac tube from bilateral cardiac progenitors both in
zebraﬁsh and in mice (George et al., 1997; Trinh and Stainier,
2004). We demonstrated that at later stages of development, in
those mouse embryos, in which heart tube is formed, FN is
required for proliferation and survival of the cardiac neural crest
(Mittal et al., 2010). However, particular aspects of cardiac devel-
opment affected by the absence of FN in these mice have not been
reported. Experiments in this paper were designed to analyze
cardiac morphogenesis in FN-null mutants, in which a single
cardiac tube has formed. We show that FN is required for
morphogenesis of the cardiac outﬂow tract. Furthermore, our
studies suggest that this effect is due to the requirement for cell
adhesion to FN for proliferation of pre-cardiac mesoderm and for
Fgf8 signaling, and that integrin α5β1 is a major mediator of FN
signaling during cardiac development.Materials and methods
Embryos
FN-null and control embryos were obtained from matings of FN-
het mice (George et al., 1993). Similarly, integrin α5-null embryos
were obtained from matings of integrin α5-het mice (Yang et al.,
1993). For in situ hybridization, embryos were ﬁxed in 4% parafor-
maldehyde at 4 1C overnight, dehydrated and stored in 100% metha-
nol at −20 1C. Plasmids encoding probes to detect ANF, Wnt11, and
BMP4 were obtained from Drs. Benoit Bruneau, Sylvia Evans and
Brigid Hogan, respectively. Cited1 mouse cDNA was from Open
Biosystems, and Cyclin D2 fragment was obtained by PCR using
mouse genomic DNA and primers 5′-gatatgcggccgcGGTCTTTTA-
GAAGTGAGAGG-3′ and 5′-gaattcgtcgacCCGTCTATGGTCTCCATCTGCC-
3′, and the 666-bp DNA fragment was subcloned into pBS-KS II
vector using Not I and Sal I restriction sites. DIG-labeled probes were
synthesized and in situ hybridization was performed according to
standard methods (Henrique et al., 1995).
Scanning electron microscopy
Embryos were collected at E9.5 and ﬁxed in 0.25% glutaralde-
hyde in PBS for at least 48 h at 4 1C, dehydrated in graded series of
ethanol and stored in 100% ethanol at −20 1C until use. Embryos
were critical-point dried and mounted using a sewing needle onto
a double-sided adhesive tape attached to a metal stub. Embryos
were then coated with gold/palladium in a DentonVacuum Desk IV
sputter coater and photographed using Zeiss Field Emission Scan-
ning Electron Microscope Supra 25.
Fate mapping studies
Isl1Cre/+ mice were mated with either FN-het or integrin α5-het
mice. FN+/−; Isl1Cre/+ males were mated with FN+/−;R26R/R26R
females to obtain FN−/−; R26R; Isl1Cre/+ embryos and controls.
Alternatively, integrin α5+/−; Isl1Cre/+ males were mated with
integrin α5+/−; R26R/R26R females. Embryos were collected at
E9.5, ﬁxed and stained using bluo-gal (Sigma) to detect LacZaccording to standard protocols. R26R reporter mice were
obtained from the Jackson labs, cat ♯3504. This strain exhibits
weak LacZ activity following Cre expression in embryos.
Immunostaining and measurements
Embryos collected at E8.75-E9.5 were ﬁxed in 4% PFA overnight
at 4 1C, and washed in PBS. MF20 antibody (Iowa developmental
hybridoma bank) was used for staining at 1:100 dilution. Primary
antibody was detected using anti-mouse secondary antibody
conjugated to horseradish peroxidase, and detected using DAB
(Vector labs). Stained embryos were dehydrated, embedded into
parafﬁn, sectioned, boiled in citric acid buffer and stained using
anti-Isl1 antibody 39.4D5, obtained from the Iowa Developmental
Hybridoma Bank. Staining using anti-pHH3 antibody and anti-
cleaved caspase 3 antibody was done as described (Mittal et al.,
2010). Proliferation was quantiﬁed by counting splanchnic meso-
dermal cells and pHH3+ cells among them. Serial sections from
4 control and 5 mutant embryos isolated at E8.75 were used. At
this stage, control and mutant embryos analyzed looked morpho-
logically similar (Mittal et al., 2010). Thickness of the myocardium
in control and FN-null embryos was measured using serial sections
from 4 control and 4 mutant E8.75 embryos. Ventral wall of the
left ventricle was measured in all cases. Similarly, the thickness of
ventricular walls in controls (n¼4) and integrin α5-null embryos
(n¼4) isolated at E9.0 was analyzed. Similar looking control and
integrin α5-null embryos were chosen for these analyses (Mittal
et al., 2010). Box plots were generated using Excel. The error bars
span the data from the minimum to the maximum numbers. The
box contains the data points within the second and third quartiles.
The line through the box marks the median.
Gene set enrichment analysis
Gene expression analyses in this paper were reported in Astrof
et al. (2007). In brief, we generated labeled mRNA from 8 FN-null
mutants (4 embryos isolated from C57BL/6J strain and 4 embryos
from 129S4 strain) and 7 control embryos isolated at the 6th
somite stage and derived from C57BL/6J (n¼4) and 129S4 genetic
background (n=3). The data reported here represents the analysis
of all FN-null vs. all wild-type embryos, and represents changes in
gene expression between mutants and controls independent of
genetic background. In order to ﬁnd pathways and biological
processes enriched in our data set, we used DAVID Bioinformatics
Resources 6.7 (http://david.abcc.ncifcrf.gov/) and the list of 609
genes, which were statistically signiﬁcantly upregulated more
than 1.7 fold in FN-null mutants compared with controls, and
had non-redundant DAVID IDs (see Supplemental ﬁle
FN_upregulaed.xls).Results
Early studies indicated that FN-null mutants die before mid-
gestation due to pronounced cardiovascular defects, the severity of
which is dependent on the genetic background (Astrof et al., 2007;
George et al., 1997). In 129S4 genetic background, FN is required
for the coalescence of the bilateral cardiac primordia to form a
single heart tube, such that FN-null embryos in this strain exhibit
cardia biﬁda. However, in C57BL/6J genetic background, FN-null
embryos contain a single heart tube (Astrof et al., 2007; George
et al., 1997). This difference in phenotype between the two strains
was mapped to a one-mega base interval on mouse chromosome 4
(Astrof et al., 2007).
However, even though the beating heart formed in FN-null
mutants in C57BL/6J background, we noticed that it was not normal
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mutants contain a linear heart tube lacking distinctive left and right
ventricles, and the stereotypical outﬂow tract (Fig. 1B). In order to
investigate cardiac development in FN-null embryos, we performed
in situ hybridization (ISH) to study gene expression patterns of
cardiac-expressed genes. At E9.5, atrial natriuretic factor (ANF) is
mainly expressed in the left ventricle, atria and to a lesser
extent in the right ventricle (Fig. 2A, C). ISH staining of FN-null
embryos showed that this pattern is also preserved in the mutants
(Fig. 2B, D). Cited1 is expressed in the left ventricle in control E9.5
embryos (Fig. 2E). And while we do not see a morphologically-
distinct left ventricle in FN-null embryos, we observed a localized
expression of Cited1 mRNA in the ventral part of the linear heart
tube in FN-null hearts, indicating that left-ventricular identity is
contained within the lower part of the linear heart tube in these
mutants (Fig. 2F). Investigation of BMP4 and Wnt11 mRNA expres-
sion demonstrated that segments containing the cardiac outﬂow
tract and the right ventricle identities are present but are much
smaller in FN-null mutants compared with controls (Fig. 3).
Shortened outﬂow tract and right ventricle have been observed
in Isl1-null, FoxH1-null and Fgf8-hypomorphic mutants (Cai et al.,
2003; Meyers et al., 1998; von Both et al., 2004). These mutants
contain hypoplastic right ventricles and short outﬂow tracts, and
similar phenotype of FN-null mutants suggest that FN is important
for the development of these structures. Cell adhesion to FN
in vitro permits cellular migration, therefore, it was possible that
the short outﬂow tracts in FN-null mutants resulted from defective
migration of cardiac progenitors into the cardiac outﬂow tract. To
examine this possibility, we checked the location of Isl1+ cells and
their descendants in FN-null mutants, using Isl1Cre knock in strain
of mice and R26R reporter mice bred into FN-null background. The
use of a weak R26R reporter variant (Jackson lab, cat ♯3504)
allowed us to follow the fate of the cardiac progenitors comprising
the anterior/second heart ﬁeld, while progenitors of the ﬁrst heart
ﬁeld, contributing to the left ventricle remained mostly unlabeled.
Similar to controls, mutant Isl1+ cells and their descendants where
already present in the heart's outﬂow tracts at E9.0 (Supplemental
Fig. 1). At E9.5, Isl1+ cells and their descendants populated the
hearts of controls and mutants, however, the outﬂow portion of
the mutant hearts (the segment connecting the left ventricle to the
arterial circulation) was abnormally short (Fig. 4). Histological
sectioning of control and FN-null embryos showed that Isl1+ cells
and their descendants are present at the right embryonic positions
within pharyngeal arches and the outﬂow tract, and that there is
no aberrant accumulation of Isl1-labeled cells in the mutants
(Fig. 4E, F). We also did not observe ectopic Isl1+ cells located
outside their expected positions in the embryos. Taken together,
these studies indicate that the migration of Is1+ cells into the heart
occurs in the expected spatio-temporal manner and does not
depend on FN. These observations are consistent with previousFig. 1. FN and integrin α5 are required for cardiac morphogenesis. Scanning electron micr
All views are ventral. LV—left ventricle, RV—right ventricle, OFT—outﬂow tract. In B an
Note dysmorphic and short RV and OFT in the mutants. Magniﬁcation is the same in alstudies demonstrating that FN is not required for cell migration
in vivo (George et al., 1997; Georges-Labouesse et al., 1996).
Short outﬂow tracts could be due to defective proliferation or
survival of myocardial cells or their precursors. Aberrant cell
survival is unlikely to contribute to the observed defect in the
outﬂow tract because we found only 10 cleaved caspase 3-positive
cells (6 in the myocardium and 4 in the splanchnic and pharyngeal
mesoderm) when we examined 59 serial sections from 5 FN-null
embryos isolated at E8.75. Moreover, our previous studies showed
no increased apoptosis in Isl1+ mesodermal cells in FN-null
embryos (Mittal et al., 2010). However, we detected nearly three-
fold decrease in cell proliferation within the splanchnic mesoderm
of our mutants (n¼5) compared with controls (n¼4) at E8.75
(Fig. 5). These observations suggest that short outﬂow tracts in FN-
null embryos result from defective proliferation of splanchnic
mesodermal cells, known to harbor cardiomyocyte precursors.
Even though the outﬂow tracts and the right ventricles were
small in our mutants, we noticed that overall, hearts in FN-null
embryos were disproportionately large compared to the overall
embryo size (Astrof et al., 2007). Indeed measuring the thickness
of left ventricles at their apex/thickest part, we found aberrant
thickening of ventricular walls in FN-null mutants (n¼4) com-
pared with controls (n¼4) (Fig. 6). We hypothesized that the
thickened myocardial wall was due to the presence of additional
layers of cardiomyocytes, and stained control and mutant embryos
using the MF20 antibody recognizing heavy chain of myosin II. Our
experiments indicate the presence of ectopic MF20+ cardiomyo-
cytes in mutants, and show that FN and integrin α5 are not
required for cardiomyocyte differentiation (Fig. 6 and data not
shown) consistent with previous observations (George et al., 1997;
Georges-Labouesse et al., 1996). Moreover, mRNA expression
proﬁling studies comparing FN-null embryos and controls con-
sisting of wild-type and heterozygous embryos isolated at E8.0
(6 somites) demonstrated a high, statistically signiﬁcant enrich-
ment in genes with a role in cardiomyocyte function and hyper-
trophic cardiomyopathy among the upregulated genes in FN-null
embryos (Table 1). We did not observe increased myocardial
proliferation in the hearts of FN-null embryos, suggesting that
ectopic cardiomyocytes could have resulted from aberrant differ-
entiation of cardiac precursors in FN-null embryos, or aberrant
allocation of cardiac precursors into the ﬁrst heart ﬁeld vs the SHF.
Taken together, these studies demonstrate a requisite role of FN in
proliferation of the splanchnic mesodermal cells, descendants of
which form the cardiac outﬂow tract, and even though distinct
cardiac parts could be identiﬁed due to marker expression and fate
mapping, we found that FN is required for the overall morphogen-
esis of the proper cardiac shape.
In order to examine potential downstream mediators of FN
signaling in the outﬂow tract development, we tested the role of
integrin α5β1 in this process. Integrins are heterodimers of oneographs of control (A), FN-null (B) and integrin α5-null (C) embryos isolated at E9.5.
d C, arrow points toward the connection of the heart with the systemic circulation.
l panels.
Fig. 2. FN is not required for cardiac chamber speciﬁcation. (A–D) Expression of ANF mRNA in control (A, C) and FN-null (B, D) hearts. ANF is expressed in the atria, the left
ventricle and to a limited extent, in the right ventricle. The expression patterns of ANF in control and FN-null embryos are comparable. Long arrow in (A) points to the
proximal OFT, and short arrow—to the distal. (E) Cited 1 mRNA is conﬁned to the left ventricle in control embryos. Inset in (E) shows the right side view. (F) Expression of
Cited 1 mRNA in FN-null heart is limited to the lower region of the straight heart tube, the presumptive left ventricle. E9.5 embryos are shown. A—atria, other abbreviations
are as in Fig. 1. Scale bars in all ﬁgures are 100 μm unless otherwise stated.
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receptors that bind ECM proteins and mediate their intracellular
signaling. α5β1 integrin heterodimer is a major cellular receptor
for FN during early embryogenesis, and genetic ablation of integrin
α5 gives rise to similar, albeit milder, morphogenetic defects,
leading to embryonic lethality by mid gestation as seen with
FN-null mutants (Yang et al., 1999, 1993).
Heart development in integrin α5-null mouse mutants has not
been investigated in detail, although, our prior studies demon-
strated aberrant cardiac looping in α5-null mice and α5-mutant
zebraﬁsh due to the requirement of integrin α5 in the establish-
ment of the left–right embryonic body plan (Pulina et al., 2011).
In order to investigate the role of integrin α5 in cardiac develop-
ment, we examined the hearts of α5-null mice using SEM and ISH(Figs. 1 and 7). These analyses demonstrated that similar to FN,
integrin α5 was required for morphogenesis of the heart's proper
shape. ISH experiments demonstrated chamber-speciﬁc gene
expression was preserved in integrin α5-null hearts, however,
hearts were misshapen and portions of the heart corresponding
to the outﬂow tract and the right ventricle were greatly reduced
(Fig. 7A–F).
We next investigated the fate of the Isl1+ cardiac progenitors in
integrin α5-null mutants, and found that Isl1+ cells and their
descendants migrate into the heart, and form a short stalk connect-
ing the left ventricle with the arterial circulation (Fig. 7G–J). Histo-
logical sectioning indicated increased thickness of the myocardial
wall due to ectopic presence of MF20+ cardiomyocytes (Fig. 6E and
data not shown). Taken together these studies indicate the
Fig. 3. The outﬂow tract and the right ventricle are speciﬁed in the absence of FN. BMP4 mRNA is expressed in the outﬂow tract of control embryo, blue dotted line (A).
In FN-null, BMP4 expression is limited to the short OFT connecting the LV to the embryo, blue dotted line. (C and D) Expression of Wnt11 mRNA. Wnt11 is expressed in the
OFT of control embryo, arrows (C) and in the short OFT of FN-null. All embryos were collected at E9.5.
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similarity in the phenotypes of FN-null and integrin α5-null mutants,
and prior literature indicating the role of integrin α5 in transducing
FN signaling (George and Hynes, 1994; Giancotti and Tarone, 2003;
Yang et al., 1999, 1993), suggest that integrin α5β1 mediates FN
signaling during cardiac morphogenesis.
Cell adhesion to FN mediated by integrin α5β1 has long been
known to regulate signaling by receptor tyrosine kinases, includ-
ing Fgf receptors (Miyamoto et al., 1996). In addition, FN binds all
known Fgf ligands (Martino and Hubbell, 2010) and syndecan-4
(Saoncella et al., 1999), a co-receptor required for Fgf and
FN-integrin mediated signaling. Thus we hypothesized that FN
modulates outﬂow tract development by regulating Fgf signaling.
Fgf8 is the main Fgf isoform regulating early cardiac development
and severe Fgf8 hypomorphs exhibit morphological defects similar
to those observed in FN-null and integrin α5-null mutants (Frank
et al., 2002; Meyers et al., 1998; Park et al., 2006, 2008). Therefore,
we assayed Fgf8 mRNA expression levels in our mutants. Our ISH
experiments indicated comparable expression of Fgf8 mRNA in
FN-null, integrin α5-null and control embryos (Supplemental
Fig. 2), indicating that neither FN nor integrin α5 are required to
regulate Fgf8 expression. Therefore, we tested the possibility that
FN and integrin α5 modulate Fgf8 signaling by assaying expression
of genes belonging to Fgf8 syn-expression group that were
previously shown to be regulated by Fgf8 signaling in early
embryos (Furthauer et al., 2002; Niehrs and Meinhardt, 2002).
Our experiments indicate that transcriptional targets downstreamof Fgf8 signaling are downregulated in FN-null and integrin
α5-null mutants compared with controls (Fig. 8A–D).
In order to determine whether cell adhesion to FN was required
to mediate Fgf8 signaling, we used a well-established in vitro
assay to test the requirement for cell adhesion to FN in potentiat-
ing Fgf8 signaling. Prior experiments indicated that binding of
integrin α5β1 to FN is required for the phosphorylation and
activation of Erk following stimulation of cells with Fgf2
(Miyamoto et al., 1996). Therefore, we tested whether cell adhe-
sion to FN co-operates with Fgf8 signaling in activating Erk. Our
experiments demonstrated that cell adhesion to FN leads to
increased levels of phosphorylated forms of Erk and that this
response is dose-dependent on the levels of Fgf8 (Fig. 8E–G). In
contrast, in the absence of cell adhesion to FN, addition of Fgf8
leads only to minimal activation of Erk (Fig. 8 E–G). These results
are consistent with prior literature demonstrating that integrin
α5β1-mediated cell adhesion to FN potentiates growth factor
signaling regulated by receptor tyrosine kinases (Giancotti and
Tarone, 2003). However, our experiments are the ﬁrst demonstra-
tion of the requirement for FN in growth factor signaling in vivo.
Prior studies demonstrated that decreased Fgf8 expression or
signaling in vivo leads to decreased proliferation of cardiac
progenitors, giving rise to defective development of the cardiac
outﬂow tract (Frank et al., 2002; Hutson et al., 2010, 2006; Meyers
et al., 1998; Park et al., 2006, 2008). Taken together, our studies
suggest that the short outﬂow tracts in FN mutants are due
defective Fgf8 signaling and attenuated proliferation of myocardial
Fig. 4. FN is required for the morphogenesis of the cardiac outﬂow tract and the right ventricle. Fate mapping of Isl1+ cells and their descendants in control (A, C, E) and FN-
null (B, D, F) embryos isolated at E9.5. Note the presence of blue cells (β-gal+) in the outﬂow tracts of the mutants. Dotted line is the plane of H&E stained sections shown in
(E and F). Regions outlined by brackets in (E and F) show thickened myocardial wall in FN-null embryos; they are expanded in Fig. 6.
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esis of the arterial pole of the heart by potentiating Fgf8 signaling.Discussion
FN-null and integrin α5-null mutants developing within the
C57BL/6J genetic background survive up to E10.5 (Astrof et al.,
2007). Even though these mutants are smaller and phenotypically
different compared with controls, gene expression studies indicate
that they are not underdeveloped, as progenitors and descendants
of all examined embryonic lineages are speciﬁed in similar spatio-temporal patterns in mutants and controls (George et al., 1997;
Georges-Labouesse et al., 1996; Mittal et al., 2010). While all
examined embryonic lineages are speciﬁed in these mutants,
morphogenesis of organs and structures such as notochord,
somites and blood vessels is defective (George et al., 1997;
Georges-Labouesse et al., 1996). Taken together, these studies
indicated that defects observed in FN-null and integrin α5-null
embryos are not due to developmental delay but due to defective
morphogenesis of correctly speciﬁed precursors into appropriate
three-dimensional structures.
Initial studies describing the phenotypes of FN-null and integ-
rin α5-null mutants were performed before the discovery of the
Fig. 5. FN is required for proliferation of cells in splanchnic mesoderm. (A and B) E8.75 control (A) and mutant (B) embryos were stained with anti-pHH3 antibody (green)
and DAPI (blue). Representative sections are shown. Splanchnic mesoderm is underlined by the dotted lines and shown enlarged in (A′ and B′). (C) Quantiﬁcation of the
fraction of pHH3+ labeled cells in splanchnic mesoderm. 4–5 sections from each embryo were analyzed, total of 413 control and 537 mutant nuclei were counted per
genotype.
Fig. 6. FN is required for normal ventricular morphogenesis. (A and B) Expression of myosin heavy chain is visualized using MF20 antibody. Dotted lines show planes of
sections in (A′, B′ and B″) below. Blue nuclei show expression of Isl1 protein. Note thickened myocardial wall in the hearts of FN-null embryos (B′, B″, D) compared with
controls (A′, C). (E) Quantiﬁcation of myocardial thickness in serial sections from control and mutant embryos. Ventral ventricular walls in 4–6 sections per embryo of serialy-
sectioned embryos were measured. In this ﬁgure, H&E panels C and D are magniﬁed views of regions indicated by the brackets in Fig. 4E and F.
Table 1
Biological processes enriched among the genes upregulated more than 1.7 fold in FN-null embryos (n¼8) compared with controls (n¼7). P is the value of probability
adjusted for multiple testing using the FDR (false discovery rate) correction. The last column lists genes in each GO category upregulated in FN-null mutants.
GO category Fold enrichment P (FDR) Genes
Myoﬁbril 14 5.22E-11 ACTA1, MYL2, CRYAB, MYBPC3, LDB3, ACTN2, MYH7, MYH6, TNNI3, TTN, TRIM63, CSRP3,
PGM5, ITGB1BP2, RYR2, SLC4A1, MYOM
Contractile ﬁber 13.6 1.06E-10 ACTA1, MYL2, CRYAB, MYBPC3, LDB3, ACTN2, MYH7, MYH6, TNNI3, TTN, TRIM63, CSRP3,
PGM5, ITGB1BP2, RYR2, SLC4A1, MYOM1
Sarcomere 15 1.25E-10 ACTA1, CRYAB, MYBPC3, LDB3, ACTN2, MYH7, MYH6, TNNI3, TTN, TRIM63, CSRP3, PGM5,
ITGB1BP2, RYR2, SLC4A1, MYOM1
Z disk 16.5 8.58E-06 PGM5, CRYAB, ITGB1BP2, LDB3, RYR2, ACTN2, SLC4A1, TTN, TRIM63, CSRP3
I band 14 3.19E-05 PGM5, CRYAB, ITGB1BP2, LDB3, RYR2, ACTN2, SLC4A1, TTN, TRIM63, CSRP3
Myosin complex 12 1.14E-04 MYL4, MYL2, DYNLL2, MYL3, MYBPC3, MYH7, MYH6, MYOM1, TTN, MYL9
Actin cytoskeleton 5.5 6.32E-04 MYL4, ACTA1, MYL2, MYL3, MYBPC3, ACTN2, MYH7, MYH6, TTN, MYL9, ANXA2, ARPC1B,
ARPC3, DYNLL2, MYOM1
Hypertrophic
cardiomyopathy
7 0.009 SLC8A1, MYL2, MYL3, MYBPC3, RYR2, MYH7, MYH6, TNNI3, TTN, CACNA2D2
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Fig. 7. Integrin α5 is not required for speciﬁcation of cardiac chambers. Control
embryos—A, C, E, G, I; integrin α5-nulls—B, D, F, H, J. (A–F) In situ hybridization. (G–J)
Fate mapping of Isl1+ cells. Abbreviations are as in Fig. 1. Scale bars are 100 μm.
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phogenesis. While dissecting FN-null embryos for a different
project, we noticed that hearts in these mutants look similar to
the hearts of Isl1-null mutants. This suggested that FN regulates
morphogenesis of the SHF derivatives, the outﬂow tract and the
right ventricle. Our ISH and fate mapping studies support this
observation.
Our previous studies demonstrated that FN and integrin α5 are
required for the establishment of the left–right embryonic body
plan, explaining the reason for aberrant cardiac looping in FN-null
and α5-null mutants (Pulina et al., 2011). In this paper, we
demonstrate that FN is required for morphogenesis of the cardiac
outﬂow tract and the right ventricle, as both structures are very
small in the mutants, and that this is likely due to defective
proliferation of the cardiac progenitors in the splanchnic meso-
derm. Intriguingly, ventricular walls of FN-null and integrin α5-
null mutants are thicker and more muscular compared with
controls, and our gene expression proﬁling data indicated upre-
gulation of many genes involved in cardiomyocyte structure and
function, and a highly statistically signiﬁcant enrichment of these
genes among the upregulated genes overall in FN-mutant embryos
(Table 1). This upregulation of cardiomyocyte structural genes was
already evident at E8.0 (6 somite stage), a very early stage in
heart development. Even though the myocardial wall was thicker,
we did not note increase in cardiomyocyte proliferation. This
suggests that FN modulates the balance between proliferation
and differentiation of cardiac progenitors.
FN is expressed by myocardial progenitors in the splanchnic
mesoderm (Mittal et al., 2010) and facilitates their proliferation
(this study). In the absence of FN (in our FN-null mutants), cardiac
progenitors may interact with other ECM glycoproteins, (e.g.
laminins) and proceed to differentiate. This possible scenario is
similar to endothelial cells, which proliferate when plated on FN
but exit from cell cycle and differentiate when plated on laminin
(Wary et al., 1996). Depending on the timing of this regulation, the
absence of FN may lead to increased differentiation of Isl1+ cells
providing ectopic cardiomyocytes for the left ventricle, and
depleting the number of Isl1+ cells allocated for the outﬂow tract
and the right ventricle. Decreased Fgf8 expression and signaling is
already known to cause precautious differentiation of cardiac
precursors into cardiomyocytes (Hutson et al., 2010; Tirosh-
Finkel et al., 2010); therefore, another possible cause of the short
outﬂow tract and the right ventricle, and ectopic cardiomyocyte
differentiation could be the imbalance in Fgf8 signaling observed
in FN and integrin α5 mutants.
FN signals to cells by interacting with cellular receptors, and
integrin α5β1 is one of the major FN receptors in vivo (Yang et al.,
1999, 1993). In vitro, multiple studies demonstrated that FN binds
α5β1 and stimulates α5β1 signaling, activating pathways regulat-
ing cell proliferation, survival, migration, remodeling of actin
cytoskeleton and others (Giancotti and Tarone, 2003; Schwartz
and Assoian, 2001). In vivo, a major role for integrin α5β1 as a FN
receptor is supported by gene knock out studies, which showed
that the phenotype of integrin α5-null embryos is similar to that of
FN-nulls (Mittal et al., 2010; Pulina et al., 2011; Takahashi et al.,
2007; Yang et al., 1999, 1993). Binding of FN to integrin α5β1
expressed on cellular surfaces leads to formation of FN ﬁbrils, and
this process is defective in integrin α5-null embryos (Pulina et al.,
2011), indicating that in early embryogenesis, FN binding and
signaling to cells is mainly dependent on integrin α5β1. Cardiac
abnormalities seen with integrin α5-null mutants are similar to
those observed in FN-null mutants. Both mutants exhibit defects
in Fgf8 signaling, while Fgf8 mRNA expression levels are not
signiﬁcantly altered. We also showed that cell adhesion to FN is
necessary to mediate Fgf8 signaling in vitro. Taken together, these
studies support a model in which cell adhesion of cardiacprecursor cells to FN mediated by integrin α5β1 and probably
additional FN-binding integrins such as those containing integrin
αv chain, regulate Fgf8 signaling and proliferation of pre-cardiac
mesoderm, and consequently, the morphogenesis of the cardiac
outﬂow tract. While detailed mechanisms remain to be investi-
gated, our studies unequivocally show that both FN and integrin
α5 are required for cardiac morphogenesis. Future studies
using these and conditional mutants will be instrumental to
determining cellular requirements for FN, integrin α5β1 and
molecular mechanisms downstream of their interactions in heart
development.
Fig. 8. Fibronectin and integrin α5 regulate Fgf8 signaling in vivo and in vitro. mRNA expression of downstream signaling reporters of Fgf8 signaling in E8.75 embryos. (A and
B) Control (top) and FN-null mutants (bottom). (C and D) Control (top) and integrin α5-null mutants (bottom). (E) Cell adhesion to FN but not to poly-d-Lys potentiates Fgf8
activation of Erk (double arrows). (F) Cell adhesion to FN mediates Fgf8 signaling in a dose-dependent manner and does not lead to increases in Erk protein levels (bottom
gel). Activation of Erk in response to cell adhesion to FN and increased doses of Fgf8 is quantiﬁed in (G).
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